메뉴 건너뛰기




Volumn 6, Issue 7, 2008, Pages 1149-1158

Diversity-oriented synthesis; A spectrum of approaches and results

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; LEAD COMPOUNDS; SPECTRUM ANALYSIS; SYNTHESIS (CHEMICAL);

EID: 41149097628     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b719372f     Document Type: Article
Times cited : (270)

References (59)
  • 6
    • 0034920256 scopus 로고    scopus 로고
    • G. MacBeath, Genome Biol., 2001, 2, 2005.2001-2005.2006
    • (2001) Genome Biol. , vol.2 , pp. 20052001-20052006
    • MacBeath, G.1
  • 7
    • 26644444285 scopus 로고    scopus 로고
    • The number of 324 validated biological targets is derived from a consensus set of small molecule drugs compiled from the FDA Orange Book, as well as biological drugs listed by the website of the Center for Biological Evaluation and Research. Those sources list 1204 distinct small molecule drugs as well as 166 distinct biologics, respectively. For 1065 of the total number of compounds a 'strong evidence of cell-based and/or in vivo evidence linking the target (and specific target sub-type) to the effect of the drug [...] alongside binding data' could be established, leading to a list of 324 distinct molecular targets with strong evidence of being implicated in the mechanism of action of those drugs. See: -202
    • M. Welch H. Mikkelsen J. E. Swatton D. S. Smith G. L. Thomas F. G. Glansdorp D. R. Spring Mol. BioSyst. 2005 1 196 202
    • (2005) Mol. BioSyst. , vol.1 , pp. 196
    • Welch, M.1    Mikkelsen, H.2    Swatton, J.E.3    Smith, D.S.4    Thomas, G.L.5    Glansdorp, F.G.6    Spring, D.R.7
  • 23
    • 11144341956 scopus 로고    scopus 로고
    • -828
    • C. M. Dobson Nature 2004 432 824 828
    • (2004) Nature , vol.432 , pp. 824
    • Dobson, C.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.